Recce Pharmaceuticals

Targeting Superbugs

Recce Limited (ASX: RCE) a pre-clinical-stage pharmaceutical company engaged in the development of a new class of antibiotics for human use.

Recce’s polymer-antibiotics are a new class of antibiotics targeted for human use, and have been developed to address the global crisis of superbugs.

RECCE CHANNEL